
GLP-1 medications alter weight loss environment by curbing hunger and reducing food intake effectively.

Actor Michael Trucco shares his home fitness routine, explaining daily workouts that keep him ready for demanding TV…

FDA clears DreaMed’s MODI system, the first CGM-based tool for automated insulin dosing in Type 2 diabetes patients…

ADARx raises $535M in IPO for RNA-targeted therapies, advancing siRNA-based treatments to degrade disease-causing proteins.

GLP-1 medications alter weight loss environment by curbing hunger and reducing food intake effectively.

Actor Michael Trucco shares his home fitness routine, explaining daily workouts that keep him ready for demanding TV…

ai3Bio raised $48 million Series A to build its immune-reset platform, a therapy that clears disease-driving cells but…

Pfizer submits oral drug Litfulo data for nonsegmental vitiligo approval, a condition affecting about 70 million people worldwide.

Sanofi invests $1 billion to deepen Regeneron partnership, accelerating four next-gen antibody treatments inspired by Dupixent’s €15.7 billion…

AI could improve social care by connecting fragmented systems and flagging risks, but it will not replace the…

Instacart and Unite Us partner on food benefits to simplify rollout of food-as-medicine initiatives for providers nationwide with…

FDA clears DreaMed’s MODI system, the first CGM-based tool for automated insulin dosing in Type 2 diabetes patients…

AI liability in healthcare raises concerns as doctors may be held responsible for mistakes made by decision-support tools,…

ADARx raises $535M in IPO for RNA-targeted therapies, advancing siRNA-based treatments to degrade disease-causing proteins.